Skip to content

Trypanocide resistance and opportunities in the era of the COVID-19 pandemic in East Africa

Trypanocide resistance and COVID

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN54255798
Enrollment
384
Registered
2022-05-23
Start date
2022-07-20
Completion date
Unknown
Last updated
2024-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antimicrobial resistance Infections and Infestations

Interventions

This will be done in the Mbarara district of southwestern Uganda. Study areas in Mbarara are Kashari, Rwampara and Biharwe subcounty. This will be done strategically leaving out the city center which

Sponsors

University of Edinburgh
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Willing and able to provide written informed consent 2. Study 1: veterinarians, farmers and veterinary drugshop sellers in Mbarara district 3. Study 2: ministerial officials, local government policymakers and key academic research contacts

Exclusion criteria

Exclusion criteria: Study I: 1. Unwilling or unable to provide written informed consent 2. Conflict of interest i.e., drug company officials and politicians Study II: 1. Unwillingness to provide consent 2. Failure to establish contact with participants due to unreliable appointments 3. Persons in influential political positions who could offer a biased opinion (e.g., opposition politicians and persons in the community)

Design outcomes

Primary

MeasureTime frame
Knowledge of, attitudes towards and practices leading to trypanocide resistance assessed using a questionnaire at a single timepoint

Secondary

MeasureTime frame
Government policy regarding trypanocide resistance assessed using interviews with policy makers at a single timepoint

Countries

Tanzania, Uganda

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026